Humanin, MOTS-c and the Mitochondrial Peptides of Aging

Every so often a longevity idea arrives that is both genuinely fascinating and instantly ripe for exploitation. Mitochondrial-derived peptides are the latest. The science is real and surprising: your mitochondria, long dismissed as simple cellular batteries, turn out to broadcast tiny protein messages that seem to matter for how you age. The exploitation is just as real: search for “humanin” or “MOTS-c” and you will find vials for sale, injectable and unregulated, promising to reverse the clock. Here is the honest gap between those two things.

What mitochondrial-derived peptides actually are

You have two genomes. The famous one lives in the nucleus of each cell. The second, far smaller one lives inside your mitochondria, a leftover of the ancient bacteria that became your cellular power plants. For a long time that mitochondrial DNA was thought to encode only a short list of proteins directly involved in producing energy.

Then researchers found something else hiding in it: short sequences that code for tiny signalling peptides. These are the mitochondrial-derived peptides, or MDPs. Rather than staying put and making energy, they are released and travel through the body, acting like hormones that influence metabolism, stress resistance and even the brain. The discovery reframed the mitochondrion as an active communicator, not just a battery — a genuinely important shift in how biologists think about aging.

Much of this field traces back to the lab of Pinchas Cohen at USC’s Leonard Davis School of Gerontology, whose group identified and characterised the first members of the family over the past two decades. That pedigree matters: this is mainstream, peer-reviewed cell biology published in serious journals, not fringe wellness. It is worth holding that distinction firmly, because the credibility of the underlying research is exactly what dubious sellers borrow when they slap a peptide name on a vial. The lab discovering a molecule and a website selling an injection of it are not the same enterprise, even when they share a word.

It also helps to understand why these peptides were missed for so long. They are encoded in short stretches of mitochondrial DNA that were previously assumed to be non-coding or purely structural, and they are small enough to slip past the standard tools biologists used to catalogue proteins. Finding them required looking specifically for tiny reading frames that conventional analysis skipped. That is part of why the field feels so fresh: we are still early in even mapping how many of these microproteins exist, let alone what each one does.

Humanin, MOTS-c and SHMOOSE

Three peptides dominate the conversation, each with a different personality.

Humanin was the first to be described. In research it behaves as a cytoprotective peptide, meaning it helps cells resist stress and death, and it has been repeatedly tied to brain aging and metabolic resilience. Lower levels have been associated with worse outcomes in various studies, which is part of why it draws so much interest.

MOTS-c is the metabolic star. It acts something like an exercise mimic, influencing insulin sensitivity and how cells burn fuel; in animal work from the Cohen lab, published in Cell Metabolism, it improved metabolic measures and countered diet-induced insulin resistance. Crucially, MOTS-c biology is closely linked to physical activity, which is one reason exercise keeps surfacing in this story.

SHMOOSE is the newcomer, identified more recently by the same group. Early work associates it with brain metabolism and Alzheimer’s-related risk, but it is the least studied of the three, and conclusions here should be held loosely.

The honest caveat across all three: most of what we know is mechanistic or associational. Much of the strongest data comes from cell cultures and animal models, where researchers can add a peptide, delete a gene, and watch what happens. Human data is largely observational — measuring peptide levels in blood and seeing what they correlate with — which is genuinely informative but cannot, on its own, prove cause and effect. Higher levels tend to track with healthier aging, but “associated with” is not “causes,” and demonstrating that raising one peptide makes a healthy person healthier is a much taller order that has not been met. That gap is not a knock on the science; it is simply where the science honestly stands, and it is precisely the gap the supplement market pretends does not exist.

The Mediterranean-diet link and the July 2026 report

The reason this topic surged back into the news is a July 2026 report, “Mediterranean Diet May Activate Tiny Proteins That Protect the Heart and Brain” (reported by ScienceDaily, 2026). It found that older adults who most closely followed a Mediterranean-style eating pattern showed differences in their mitochondrial-derived peptides, hinting that the diet may influence aging partly through this pathway.

That is a satisfying result because it connects two well-regarded lines of evidence. The Mediterranean diet already has one of the strongest track records of any dietary pattern for cardiovascular and brain health. If part of its benefit runs through MDPs, that is a plausible mechanism, not a marketing invention. But note the shape of the finding: it is an association in older adults, not a trial proving the diet raises a peptide which then extends healthspan. It is a good reason to eat well, not a peptide loophole.

The same logic applies to exercise. Because MOTS-c behaves like an exercise-responsive molecule, physical activity is a leading candidate for nudging this system in a healthy direction — and exercise, conveniently, is the single most evidence-backed longevity intervention we have regardless of peptides.

Why higher levels associate with healthier aging

Put simply, MDPs appear to be markers and possibly mediators of well-functioning mitochondria. When your mitochondrial machinery is in good shape — supported by movement, sensible eating and recovery — these peptides tend to be present at levels linked with better metabolic and cognitive aging. When mitochondrial function declines, as it tends to with age, the signalling appears to weaken too.

This is exactly the same neighbourhood as the rest of the longevity conversation. It overlaps with how people think about protecting NAD+ levels naturally, another mitochondria-adjacent story where the biology is real but the supplement hype outpaces the human evidence. The pattern repeats because the underlying truth repeats: mitochondrial health responds to lifestyle far more reliably than to anything in a bottle.

The honest reality: there is no supplement to buy

Here is the part the marketing buries. There is no proven humanin, MOTS-c or SHMOOSE supplement. No oral product has good evidence that it raises your levels of these peptides or improves your health by doing so.

What you will find online are injectable peptides sold as “research chemicals.” These are unregulated, of unverified purity and untested for safety in anti-aging use. Injecting an unknown-quality compound to chase a biomarker that has never been shown to help healthy people is a genuinely risky trade. It is the same failure mode as injectable and IV longevity products generally: bypass the trials, go straight to testimonials, charge a premium. When a molecule is legitimately interesting, that interest gets weaponised fastest by the least accountable sellers.

If your goal is simply better day-to-day energy, it is far more productive to start with the fundamentals we cover in the best supplements for energy and to rule out ordinary causes, rather than reaching for an experimental injectable.

What you can actually do

The useful levers here are unglamorous and familiar, which is a feature, not a bug:

• Eat a whole-food pattern, with the Mediterranean diet the best-supported option and now the one specifically linked to these peptides in the July 2026 report.
• Exercise regularly. Given MOTS-c’s exercise-responsive biology and exercise’s unmatched longevity evidence, this is the closest thing to a real “MDP intervention” you have.
• Protect sleep and manage stress, since mitochondrial function suffers under chronic disruption.

These are the same levers that show up for spermidine and autophagy and across the whole longevity field, and that consistency is the point: there is no shortcut that beats them.

Realistic expectations

Mitochondrial-derived peptides are one of the more exciting frontiers in aging biology, and the researchers behind them are doing serious science. It is entirely possible that within a decade there are validated ways to measure and even therapeutically modulate MDPs. But that day has not arrived. Today, the honest position is that higher levels associate with healthier aging, diet and exercise appear to support them, and no product you can buy has earned your trust or your needle.

Treat this as a reason to double down on the basics with a little extra motivation, not as a new thing to purchase. The peptides are real. The supplement is not.

This article is for general information and is not medical advice. Talk to a qualified clinician before starting any supplement or peptide, especially if you have a health condition or take medication.